Your session is about to expire
← Back to Search
Cognitive Remediation Therapy for Depression (CogRemVet Trial)
N/A
Recruiting
Led By Erin A Hazlett-Oakes, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in pre-treatment score minus post-treatment score (week 10)
Awards & highlights
Summary
This trial is testing a new cognitive remediation therapy that includes "Bridging" sessions to help Veterans with major depressive disorder and a history of suicide attempt(s).
Who is the study for?
This trial is for U.S. Veterans aged 18-60 with major depressive disorder and a history of suicide attempts within the past year. They must have current suicidal thoughts without immediate plans to act on them, be in ongoing psychotherapy, and score high on rumination measures. Women are encouraged to participate, aiming for at least 30% female participants.
What is being tested?
The study tests a new cognitive therapy called NEAR (Cognitive Remediation plus Bridging) delivered via telehealth over 10 weeks with 20 sessions. It's designed to help veterans improve decision-making and manage stressors that could lead to suicidal thoughts by practicing problem-solving strategies.
What are the potential side effects?
Since this intervention involves educational and therapeutic activities rather than medication, typical medical side effects are not expected. However, participants may experience emotional discomfort or fatigue during mental exercises.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change in pre-treatment score minus post-treatment score (week 10)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in pre-treatment score minus post-treatment score (week 10)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Mental Depression
Trial Design
1Treatment groups
Experimental Treatment
Group I: Cognitive Remediation+Bridging InterventionExperimental Treatment1 Intervention
This is a pilot study to collect feasibility data on this novel cognitive remediation intervention for Veterans at high risk for suicide. All patients will receive the active intervention.
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,647 Previous Clinical Trials
3,360,034 Total Patients Enrolled
79 Trials studying Depression
19,944 Patients Enrolled for Depression
Erin A Hazlett-Oakes, PhDPrincipal InvestigatorJames J. Peters Veterans Affairs Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are a military veteran from the United States.You have a high score on a test that measures how much you think about the same things over and over.You have had a head injury in the past.You must be between 18 and 60 years old.You have serious difficulty with thinking and understanding things.You have been diagnosed with major depressive disorder (MDD) and have attempted suicide in the past year.You have thoughts about wanting to die or have a plan to harm yourself.You are currently receiving regular psychotherapy at the James J. Peters VA Medical Center.You currently have a problem with using drugs or alcohol.You have a neurological disorder or another medical condition that could affect the study results.
Research Study Groups:
This trial has the following groups:- Group 1: Cognitive Remediation+Bridging Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger